{"database": "openregs", "table": "documents", "rows": [["FDA-2015-D-1211-0360", "FDA", "FDA-2015-D-1211", "Recommendations for Evaluating Donor Eligibility Using Individual Risk- Based Questions To Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2023-05-12T04:00:00Z", 2023, 5, "2023-05-12T04:00:00Z", null, "2023-05-12T12:59:32Z", "2023-10252", 0, 0, "09000064859fa444"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-D-1211-0360"], "units": {}, "query_ms": 80.0030140671879, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}